Acupuncture may provide modest reductions in aromatase inhibitor-related joint pain in postmenopausal women with early-stage breast cancer, results of a multicenter study suggest.
Increased adiposity is associated with a decreased risk for developing breast cancer before menopause, confirms a pooled analysis published in JAMA Oncology.
Two opposing sets of phase III results regarding the effect of denosumab on the recurrence of hormone receptor-positive nonmetastatic breast cancer have been presented at the ASCO Annual Meeting 2018 in Chicago, Illinois, USA.
Adding ovarian suppression to tamoxifen significantly improves disease-free survival over tamoxifen alone in premenopausal women with hormone receptor-positive breast cancer, the latest data from the SOFT and TEXT trials show.
Joseph Sparano gives an overview of his team's findings regarding a 21-gene prognostic test that could help tailor treatment for women with early breast cancer.
Funding for this video was provided in part by F. Hoffmann-La Roche Ltd, Basel, Switzerland.